i
Superseded
This Document Has Been Replaced By:
i
Retired
This Document Has Been Retired
i
Up-to-date Information
This is the latest update:
Sox4 is a key oncogenic target in C/EBPα mutant Acute Myeloid Leukemia
-
Published Date:
Oct 31 2013
-
Publisher's site:
-
Source:Cancer Cell. 2013; 24(5):575-588.
-
Details:
-
Alternative Title:Cancer Cell
-
Personal Author:
-
Description:Mutation or epigenetic silencing of the transcription factor C/EBPα is observed in ∼10% of patients with acute myeloid leukemia (AML). In both cases, a common global gene expression profile is observed, but downstream targets relevant for leukemogenesis are not known. Here, we identify Sox4 as a direct target of C/EBPα whereby its expression is inversely correlated with C/EBPα activity. Downregulation of Sox4 abrogated increased self-renewal of leukemic cells and restored their differentiation. Gene expression profiles of leukemia-initiating cells (LICs) from both Sox4 overexpression and murine C/EBPα mutant AML models clustered together but differed from other types of AML. Our data demonstrate that Sox4 overexpression resulting from C/EBPα inactivation contributes to the development of leukemia with a distinct LIC phenotype.
-
Subject:
-
Pubmed ID:24183681
-
Pubmed Central ID:PMC4038627
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
image/jpeg image/gif image/jpeg image/gif image/jpeg image/gif image/jpeg image/gif image/jpeg application/msword application/vnd.ms-excel application/octet-stream image/gif image/jpeg image/gif image/jpeg image/gif
No Related Documents.